Grünelabs Presents


Meroflex is a highly standardized pharmaceutical product derived from two chemovars of Cannabis sativa, predominantly CBD in a ratio of 2: 1 to THC.

Cannabidiol (CBD), a non-euphoric phytocannabinoid common in our plants, has neuroprotective effects with THC and shows higher antioxidant activity than ascorbic acid (vitamin C) or tocopherol (vitamin E).

These cannabinoids also suppress chemotherapy-induced pain (vincristine-induced allodynia) through activation of the receptors of the endocannabinoid system in the spinal cord, it is also peripherally active where CB2 stimulation reduces pain and inflammation.

The anti-inflammatory contributions of THC are also extensive, THC has twenty times the anti-inflammatory potency of aspirin and twice the strength of hydrocortisone, with fewer side effects.